Elevance Health (ELV)Rep. Rob Bresnahan (PA08) disclosed a sale $15K–$50K
Rep. Rob Bresnahan (PA08) disclosed a sale of Elevance Health in the $15K–$50K range.
- $15,001–$50,000
- Reported range · official band, not an exact amount
- 16 days
- Disclosure lag
- Traded
- May 15, 2025
- Disclosed
- May 31, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 29, 2024CongressDisclosed purchase of ELV — reported range $1,001 - $15,000
- Jan 13, 2025CongressDisclosed sale of ELV — reported range $1,001 - $15,000
- Mar 10, 2025Congress · 1 personMembers of Congress: 3 sales
- Apr 11, 2025CongressDisclosed partial sale of ELV — reported range $1,001 - $15,000
- Apr 24, 2025InsiderCFO sold ~$1.95M of ELV shares in the open market
- Apr 29, 2025CongressDisclosed purchase of ELV — reported range $1,001 - $15,000
- May 12, 2025Court · District Court, S.D. IndianaSecurities lawsuit filed: MILLER v. ELEVANCE HEALTH, INC.
- May 12, 2025CongressDisclosed sale of ELV — reported range $15,001 - $50,000
- May 15, 2025 · this disclosureCongressDisclosed sale of ELV — reported range $15,001 - $50,000
What came next
- May 30, 2025CongressDisclosed sale of ELV — reported range $1,001 - $15,000
- Jun 24, 2025CongressDisclosed purchase of ELV — reported range $1,001 - $15,000
- Jul 10, 2025Congress · 1 personMembers of Congress: 2 purchases
- Jul 18, 2025Insider · 1 personInsiders: 3 purchases (~$2.4M)
- Aug 5, 2025CongressDisclosed purchase of ELV — reported range $1,001 - $15,000
- Aug 13, 2025CongressDisclosed sale of ELV — reported range $1,001 - $15,000
- Aug 19, 2025InsiderDirector purchased ~$375K of ELV shares in the open market
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Elevance Health
For Elevance Health, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 37 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ELV page.
Other recent filings by Rep. Rob Bresnahan (PA08)
- House Clerk periodic transaction report at Berkshire Hathaway (BRK.B)Dec 19, 2025
- House Clerk periodic transaction report at Gitlab (GTLB)Jul 8, 2025
- House Clerk periodic transaction report at Amazon (AMZN)Jul 8, 2025
- House Clerk periodic transaction report at AppLovin (APP)Jul 8, 2025
- House Clerk periodic transaction report at Atlassian (TEAM)Jul 8, 2025
The full history of Rep. Rob Bresnahan (PA08) is on the profile page.
How this filing works
Other disclosures at Elevance Health
- SEC Form 13F-HRAug 20, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its ELV page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
